You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Details for Patent: 8,501,238


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,501,238
Title:Anti-infective agents and uses thereof
Abstract: This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
Inventor(s): Flentge; Charles A. (Salem, WI), Hutchinson; Douglas K. (Antioch, IL), Betebenner; David A. (Libertyville, IL), DeGoey; David A. (Salem, WI), Donner; Pamela L. (Mundelein, IL), Kati; Warren M. (Gurnee, IL), Krueger; Allan C. (Gurnee, IL), Liu; Dachun (Waukegan, IL), Liu; Yaya (Buffalo Grove, IL), Longenecker; Kenton L. (Grayslake, IL), Maring; Clarence J. (Palatine, IL), Motter; Christopher E. (Oak Creek, WI), Pratt; John K. (Kenosha, WI), Randolph; John T. (Libertyville, IL), Rockway; Todd W. (Grayslake, IL), Stewart; Kent D. (Gurnee, IL), Wagner; Rolf (Antioch, IL), Chen; Shuang (Gurnee, IL), Gao; Yi (Vernon Hills, IL), Lou; Xiaochun (Long Grove, IL), Zhang; Geoff G. Z. (Libertyville, IL)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:13/451,889
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Process;
Patent landscape, scope, and claims:

United States Patent 8,501,238: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,501,238, titled "Anti-infective agents and uses thereof," is a significant patent in the field of pharmaceuticals, particularly in the treatment of infectious diseases. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Publication and Authority

The patent, US8501238B2, was granted by the United States Patent and Trademark Office (USPTO) and is currently active, although its expiration date is listed as part of its legal status[4].

Inventors and Assignees

While the specific inventors and assignees are not detailed here, it is crucial to note that the patent is associated with a specific entity or individual who has the rights and responsibilities tied to the invention.

Prior Art and Related Patents

The patent builds upon prior art in the field of anti-infective agents, particularly those targeting Hepatitis C Virus (HCV). The prior art keywords include terms like "group," "crystalline," "tert-butyl," and "naphthalen," indicating the chemical nature of the invention[4].

Scope of the Patent

Invention Description

The patent describes compounds and salts thereof that inhibit HCV, along with intermediates useful for the preparation of these compounds. The invention includes various chemical substances, such as solvates, and methods for their preparation and use[4].

Claim Structure

The claims of the patent are structured to define the scope of the invention. Here, the claims include:

  • Independent Claims: These define the broadest scope of the invention. For example, Claim 1 might describe a compound with specific structural features.
  • Dependent Claims: These narrow down the scope by adding additional limitations to the independent claims. For instance, a dependent claim might specify a particular salt form of the compound.
  • Method Claims: These claims cover the methods of preparing and using the compounds[4].

Metrics for Measuring Patent Scope

Research has shown that patent scope can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as measured by these metrics, are often associated with a higher probability of grant and a shorter examination process[3].

Claim Length and Count

In the case of US8501238B2, the claims are detailed and specific, indicating a well-defined scope. The examination process likely narrowed the scope of the claims to ensure clarity and validity.

Chemical Substances and Methods

Compounds and Salts

The patent details various compounds and their salts that are effective against HCV. These include specific chemical structures and their corresponding salts, such as sodium and other solvates[4].

Intermediates and Preparation Methods

The invention also covers intermediates used in the preparation of these anti-infective agents. Methods for synthesizing these compounds, including powder X-ray diffraction and other analytical techniques, are described in detail[4].

Patent Landscape

Global Patent Family

To understand the broader patent landscape, it is essential to look at the global patent family. Tools like the Global Dossier provided by the USPTO allow users to see related applications filed at participating IP Offices, including the IP5 Offices (USPTO, EPO, JPO, KIPO, and CNIPA)[1].

International Patent Databases

Searching international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can reveal similar or related patents filed in other jurisdictions. This helps in understanding the global reach and potential overlaps or conflicts with other patents[1].

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and related patents. This tool replaced legacy search tools and provides enhanced access to prior art, which is crucial for analyzing the scope and claims of a patent like US8501238B2[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, allowing users to visualize search results for the same invention on a single page. This tool is particularly useful for understanding how different offices have treated similar patent applications[1].

Practical Implications

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation. Broader claims may lead to increased licensing and litigation costs, while narrower claims can provide clearer boundaries and reduce potential disputes[3].

Innovation Incentives

The clarity and validity of patent claims can influence innovation incentives. Patents with well-defined scopes and clear claims can encourage further innovation by providing a clear understanding of what is protected and what is open for further development[3].

Key Takeaways

  • Patent Scope: The scope of US8501238B2 is defined by its claims, which include specific compounds, salts, and methods for their preparation and use.
  • Claim Metrics: The patent's claims are likely to have been narrowed during the examination process to ensure clarity and validity.
  • Global Landscape: Understanding the global patent family and searching international databases are crucial for analyzing the broader patent landscape.
  • Search Tools: Utilizing tools like Patent Public Search and CCD can help in detailed analysis and prior art search.
  • Practical Implications: The clarity and validity of the patent claims can impact licensing, litigation, and innovation incentives.

FAQs

Q: What is the main subject of United States Patent 8,501,238?

A: The main subject of US8501238B2 is anti-infective agents, specifically compounds and salts that inhibit Hepatitis C Virus (HCV).

Q: How can one measure the scope of a patent like US8501238B2?

A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

Q: What tools are available for searching prior art related to US8501238B2?

A: Tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are available for searching prior art.

Q: Why is it important to analyze the global patent family of US8501238B2?

A: Analyzing the global patent family helps in understanding related applications filed in other jurisdictions, which can reveal potential overlaps or conflicts.

Q: How do the claims of US8501238B2 impact licensing and litigation?

A: The clarity and validity of the claims can reduce licensing and litigation costs by providing clear boundaries of what is protected.

Sources

  1. USPTO: Search for patents - USPTO
  2. PubChem: Anti-infective agents and uses thereof - Patent US-8501238-B2
  3. SSRN: Patent Claims and Patent Scope
  4. Google Patents: US8501238B2 - Anti-infective agents and uses thereof
  5. Regulations.gov: FDA U.S. FOOD & DRUG OCT 1 0 2010 - Regulations.gov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,501,238

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Abbvie VIEKIRA PAK (COPACKAGED) dasabuvir sodium; ombitasvir, paritaprevir, ritonavir TABLET;ORAL 206619-001 Dec 19, 2014 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y Y USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION. ⤷  Try for Free
Abbvie VIEKIRA XR dasabuvir sodium; ombitasvir; paritaprevir; ritonavir TABLET, EXTENDED RELEASE;ORAL 208624-001 Jul 22, 2016 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y Y USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION. ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 2 of 2 entries

International Family Members for US Patent 8,501,238

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 2203431 ⤷  Try for Free 15C0013 France ⤷  Try for Free
European Patent Office 2203431 ⤷  Try for Free CA 2015 00014 Denmark ⤷  Try for Free
European Patent Office 2203431 ⤷  Try for Free C20150015 00143 Estonia ⤷  Try for Free
European Patent Office 2203431 ⤷  Try for Free PA2015013 Lithuania ⤷  Try for Free
European Patent Office 2203431 ⤷  Try for Free 92666 Luxembourg ⤷  Try for Free
European Patent Office 2203431 ⤷  Try for Free 1590018-6 Sweden ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.